Press releases | WebDisclosure

Basculer en Français

10372	Companies
216173	Keywords
145882	Articles
114461	Press releases

Home
Press releases

PRESS RELEASE

published on 04/23/2026 at 07:30, 17 days 3 hours ago

OSE Immunotherapeutics annonce la présentation des résultats de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire au Congrès 2026 de l’ASCO
OSE Immunotherapeutics annonce la présentation des résultats de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire au Congrès 2026 de l’ASCO. Présentation orale le 30 mai 2026, à Chicago, Etats-Unis

Étude De Phase 2 OSE Immunotherapeutics ASCO Cancer De L'ovaire TEDOVA
PRESS RELEASE

published on 04/23/2026 at 07:30, 17 days 3 hours ago

OSE Immunotherapeutics Announces Presentation of TEDOVA Phase 2 Topline Results of Tedopi® in Ovarian Cancer at the ASCO 2026 Meeting
OSE Immunotherapeutics announces topline results from TEDOVA Phase 2 trial of Tedopi® in Ovarian Cancer at ASCO 2026 Meeting. Presentation by lead investigator Alexandra Leary, MD, PhD

Ovarian Cancer OSE Immunotherapeutics Tedopi® TEDOVA Phase 2 ASCO 2026
PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million
Helvetia Baloise successfully places three senior bond tranches totalling CHF 550 million on Swiss capital market. Proceeds for corporate purposes & potential refinancing. Strong investor demand

Investor Demand Swiss Capital Market Helvetia Baloise Senior Bond Tranches CHF 550 Million
PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Sartorius marks positive start to 2026: Considerable sales revenue growth and resilient profit margin
Sartorius AG marks positive start to 2026 with 7.5% sales revenue growth and 29.7% profit margin. Full-year guidance confirmed. Bioprocess Solutions grows by 8.1%

Sartorius AG Full-year Guidance Profit Margin Bioprocess Solutions Sales Revenue Growth
PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026
Sartorius Stedim Biotech reports robust first-quarter results for fiscal 2026 with sales revenue up 7.9% in constant currencies. Profitability remains strong with a margin of 30.7% and net profit of 88 million euros

Profitability Sartorius Stedim Biotech Sales Revenue First-quarter Results Fiscal 2026
PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l’exercice 2026
Sartorius Stedim Biotech publie de bons résultats pour le premier trimestre de l'exercice 2026, avec un chiffre d'affaires en hausse de 7,9% à taux de change constant

Chiffre D'affaires Croissance EBITDA Sartorius Stedim Biotech Résultat Trimestriel
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

bioMérieux – First-Quarter 2026 Business Review
bioMérieux reports -3.9% organic sales decline in Q1 2026 due to weaker respiratory season and geopolitical factors. Revises 2026 guidance. CEO emphasizes innovation and cost control for positive CEBIT evolution

Innovation BioMérieux Sales Decline 2026 Guidance CEBIT Evolution
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Safran reports first quarter 2026 revenue
Safran reports strong Q1 2026 revenue growth of 18.8%, CEO expresses confidence in full-year outlook, details key division performances and currency hedging strategy

Safran Revenue Growth CEO Statement Currency Hedging Q1 2026
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Edenred records sustained growth in Q1 and confirms its objectives for 2026 and beyond
Edenred reports +8.2% revenue growth in Q1 2026, maintains objectives for 2026. Receives 'A' rating from CDP for ESG leadership. Amplify25-28 strategic plan execution continues

Edenred Revenue Growth Q1 2026 CDP 'A' Rating Amplify25-28
REGULATED PRESS RELEASE

published on 04/23/2026 at 07:00, 17 days 3 hours ago

Safran publie son chiffre d’affaires du 1er trimestre 2026
Safran publie son chiffre d'affaires du 1er trimestre 2026 avec une forte croissance. Perspectives confirmées pour l'année. Communiqué détaillé sur les activités et performances financières

Chiffre D'affaires Croissance Safran Performances Financières Trimestre 2026

Accesswire

Published on 05/09/2026 at 01:55, 1 day 8 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 9 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 9 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 10 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 11 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/09/2026 at 19:05, 15 hours 41 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 14 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 15 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 1 day 15 hours ago

Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/08/2026 at 18:29, 1 day 16 hours ago

Designated Person Notification

Les Echos

Published on 05/07/2026 at 19:15, 2 days 15 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 15 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 15 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 15 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE